A recent transaction has seen Covington & Burling’s London office advising AstraZeneca on a significant financial endeavor. The pharmaceutical giant has moved to acquire EsoBiotec, a Belgian biotechnology firm, for $1 billion. This acquisition is a substantial move for AstraZeneca, which holds the largest market capitalization on the FTSE 100, valued at £185.9 billion.
AstraZeneca confirmed this acquisition in an announcement to the London Stock Exchange. For further details on this development, you can find more information in the original article.